Pulmonary embolism is an acute obstruction of pulmonary arteries, usually by thrombus, that can cause dyspnea, chest pain, right heart strain, and sudden death if severe.
The FDA has approved labeling changes to six menopausal hormone therapy products, removing boxed warnings related to cardiovascular disease, breast cancer, and probable dementia that had been in place since 2003.
The FDA approved pembrolizumab (Keytruda) and Keytruda Qlex plus paclitaxel, with or without bevacizumab, for adults with PD-L1+ platinum-resistant ovarian carcinoma based on Phase 3 trial data showing improved survival outcomes.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07603700 |
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism |
NOT_YET_RECRUITING | |
| NCT07381712 |
High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism. |
ACTIVE_NOT_RECRUITING | NA |
| NCT07356908 |
Impact of Sleep Related Breathing Disorders on Outcomes of Acute Pulmonary Embolism |
COMPLETED | |
| NCT07350499 |
Aspiration Thrombectomy Using the Symphony or Prodigy System |
RECRUITING | |
| NCT07313501 |
Evaluation of the PERC Score and the YEARS Algorithm in the Diagnosis of Pulmonary Embolism in the Emergency Department |
RECRUITING | |
| NCT07250763 |
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital |
ACTIVE_NOT_RECRUITING | PHASE4 |
| NCT07249385 |
Nudging Provider Adoption of Clinical Decision Support: Implementation of an EHR-Agnostic Pulmonary Embolism Risk Prediction Tool |
NOT_YET_RECRUITING | NA |
| NCT07003646 |
Reperfusion Treatment in Acute Pulmonary Embolism |
RECRUITING | |
| NCT06912009 |
Duration of Therapeutic Anticoagulation in Patients With Pulmonary Embolism |
RECRUITING | |
| NCT06753786 |
Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage |
RECRUITING | NA |
